Cargando…
Risk of hypertension in Cancer patients treated with Abiraterone: a meta-analysis
BACKGROUND: Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials to deter...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442407/ https://www.ncbi.nlm.nih.gov/pubmed/30984412 http://dx.doi.org/10.1186/s40885-019-0110-3 |
Search Result 1